✦ LIBER ✦

No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22

✍ Scribed by Liping Luo; Haixin Lei; Quan Du; Anna von Wachenfeldt; Ingrid Kockum; Holger Luthman; Igor Vorechovsky; Annika Lindblom

Publisher: John Wiley and Sons
Year: 2002
Tongue: French
Weight: 57 KB
Volume: 98
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.10214

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No mutations in the XRCC2 gene in BRCA1/

No mutations in the XRCC2 gene in BRCA1/2-negative high-risk breast cancer families

✍ Raquel Rodríguez-López; Ana Osorio; Luis Sánchez-Pulido; Miguel de la Hoya; Alic 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 43 KB

About 5-10% of breast cancer cases are hereditary and attributable to mutations in several susceptibility genes from which to date only 2 have been identified: BRCA1 (17q21) and BRCA2 (13q12). However, the BRCA genes only explain about 30% of familial breast/ovarian cancer, suggesting the existence

Breast cancer incidence, penetrance and

Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12–21

✍ Mr D. E. Porter; B. B. Cohen; M. R. Wallace; E. Smyth; U. Chetty; J. M. Dixon; C 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB

Novel germline mutations in the BRCA1 an

Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families

✍ Mani T. Valarmathi; Meenakshi Sawhney; Suryanarayana S. V. Deo; Nootan K. Shukla 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

The two major hereditary breast/ovarian cancer predisposition tumor suppressor genes, BRCA1 and BRCA2 that perform apparently generic cellular functions nonetheless cause tissue-specific syndromes in the human population when they are altered, or mutated in the germline. However, little is known abo

Germline mutations of the BRCA1-associat

Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations

✍ Chiara Ghimenti; Elisa Sensi; Silvano Presciuttini; Isa Maura Brunetti; PierFran 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 3 views

## Abstract BARD1 (BRCA1‐associated RING domain) was identified by yeast two‐hybrid screening as a protein interacting with BRCA1. Somatic and germline mutations of __BARD1__ have been detected in sporadic breast, ovarian, and endometrial cancers. The present study represents the first description

Germline mutations in the BRCA1 and BRCA

Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients

✍ A. Esra Manguoǧlu; Güven Lüleci; Tayfun Özçelik; Taner Çolak; Hagit Schayek; Mus 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 2 views

In this study we genotyped Turkish breast/ovarian cancer patients for BRCA1/BRCA2 mutations: protein truncation test (PTT) for exon 11 BRCA1 of and, multiplex PCR and denaturing gradient gel electrophoresis (DGGE) for BRCA2, complemented by DNA sequencing. In addition, a modified restriction assay w

Mutational analysis of the BRCA1-interac

Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals

✍ Joni L. Rutter; Amelia M. Smith; Michael R. Dávila; Alice J. Sigurdson; Ruthann 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

Two potential breast cancer susceptibility genes, encoding the BRCA1-interacting proteins ZNF350 (or ZBRK1) and BRIP1 (or BACH1), have been identified in yeast two-hybrid screens. We sequenced these genes in probands from 21 families with potentially inherited breast/ovarian cancer, all of which wer